OCON Healthcare
CEO: Keren Leshem
OCON Healthcare is the first and only to offer a validated, physiologically adapted intrauterine drug delivery platform. OCON has created the world’s first three-dimensional (3D) spherical intrauterine drug-delivery technology that is ideally shaped for the female anatomy. As a result, it can address a myriad of women’s health issues through the uterus while avoiding the systemic side effects from taking oral formulations.
OCON’s first product, IUB™ Ballerine, is a long-term birth control method that requires no hormones and is over 99% effective against pregnancy for up to 5 years. OCON’s second market-changing product is the IUB™ SEAD™ which is an innovative yet gentle substance-derived ablation technology.